Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANTHARIDIN vs CAPIVASERTIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANTHARIDIN vs CAPIVASERTIB: Safety Overview

Metric CANTHARIDIN CAPIVASERTIB
Total FAERS Reports 114 1,691
Deaths Reported 0 285
Death Rate N/A 16.9%
Hospitalizations 3 464
Average Patient Age 17.6 yrs 66.2 yrs
% Female Patients 53.3% 94.6%
FDA Approval Date Jul 21, 2023 Nov 16, 2023
Manufacturer Verrica Pharmaceuticals Inc. AstraZeneca Pharmaceuticals LP
Route TOPICAL ORAL
Marketing Status Prescription Prescription